BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Short (1M)
Nirmal Bang Recommends 'Accumulate' On Lupin
According to Nirmal Bang, Lupin remains the preferred partner for in-licensing deals in opportune markets like cardio diabetes by virtue of its leadership position.